Intended for healthcare professionals

Education And Debate

Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold

BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7181.456 (Published 13 February 1999) Cite this as: BMJ 1999;318:456